Validea Canada: Guru Stock Analysis - Cipher Pharmaceuticals Inc

Strategy	Guru Based on	Strategy Description	Score Scores above 90% typically indicate strong interest. Scores above 70%-80% typically indicate some interest.
P/E/Growth Investor	Peter Lynch	This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.	74%
Small-Cap Growth Investor	Motley Fool	This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.	72%
Book/Market Investor	Joseph Piotroski	This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving financial criteria.	70%
Contrarian Investor	David Dreman	This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.	50%
Growth Investor	Martin Zweig	This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.	46%
Growth/Value Investor	James P. O'Shaughnessy	This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative strength.	25%
Low PE Investor	John Neff	This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.	23%
Momentum Investor	Validea	This momentum strategy looks for companies with strong price momentum and EPS growth that is coupled with high return on equity and falling debt.	21%
Price/Sales Investor	Kenneth Fisher	This value strategy that rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.	20%
Value Investor	Benjamin Graham	This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.	14%
Earnings Yield Investor	Joel Greenblatt	This value model that looks for companies with high return on capital and earnings yields.	0%
Patient Investor	Warren Buffett	This strategy seeks out firms with long-term, predictable profitability and low debt that trade at reasonable valuations.	0%

Cipher Pharmaceuticals Inc (CPH)

Guru Analysis based on 1/14/2025 close price.